MRIGlobal works with animal vaccine company on human Covid-19 vaccine

MBF Therapeutics, which to date has focused on developing DNA-based vaccines for animals, said Thursday it has formed a collaboration with four life science industry partners to work on a Covid-19 vaccine for humans. The collaboration with MRIGlobal, Rymedi, SSI Strategy and Aldevron will seek to advance MBF Therapeutics’ SARS CoV-2 vaccine candidate COVE-001. Financial terms of the partnership are being kept confidential. “Our goal is a better long-term solution to the current global pandemic,"…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news